» Articles » PMID: 32611956

Severe Bradycardia Induced by Sofosbuvir and Amiodarone Which Resolved After the Discontinuation of Both Drugs

Overview
Journal Intern Med
Specialty General Medicine
Date 2020 Jul 3
PMID 32611956
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Amiodarone, prescribed for cardiac conditions, including dysrhythmia, is associated with bradycardia. However, few reports have demonstrated that bradycardia is observed when amiodarone is used in combination with sofosbuvir, a direct-acting antiviral drug for chronic hepatitis C. We herein report the case of a male patient in his 70s with chronic atrial fibrillation and prostatic hyperplasia and was also taking amiodarone, who experienced severe bradycardia and syncope a day after taking sofosbuvir and ribavirin for chronic hepatitis C. After discontinuing amiodarone, ribavirin, and sofosbuvir, bradycardia did not recur. Therefore, we must consider drug interactions between amiodarone and sofosbuvir in patients with severe bradycardia.

Citing Articles

Effectiveness of pharmacological cardioversion of new-onset atrial fibrillation during thoracic surgery operations: a single-centre experience.

Wu D, Li Q, Xu M, Wu J, Yang J J Cardiothorac Surg. 2023; 18(1):113.

PMID: 37029419 PMC: 10082476. DOI: 10.1186/s13019-023-02236-y.

References
1.
Back D, Burger D . Interaction between amiodarone and sofosbuvir-based treatment for hepatitis C virus infection: potential mechanisms and lessons to be learned. Gastroenterology. 2015; 149(6):1315-7. DOI: 10.1053/j.gastro.2015.09.031. View

2.
Moya A, Sutton R, Ammirati F, Blanc J, Brignole M, Dahm J . Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009; 30(21):2631-71. PMC: 3295536. DOI: 10.1093/eurheartj/ehp298. View

3.
Shen W, Sheldon R, Benditt D, Cohen M, Forman D, Goldberger Z . 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2017; 70(5):e39-e110. DOI: 10.1016/j.jacc.2017.03.003. View

4.
Renet S, Chaumais M, Antonini T, Zhao A, Thomas L, Savoure A . Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge. Gastroenterology. 2015; 149(6):1378-1380.e1. DOI: 10.1053/j.gastro.2015.07.051. View

5.
Calkins H, Shyr Y, Frumin H, Schork A, Morady F . The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope. Am J Med. 1995; 98(4):365-73. DOI: 10.1016/S0002-9343(99)80315-5. View